微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 3.19% | -34.5% | -64.59% | 16/139 | 1.16% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | 9.01% | -21.24% | -19.91% | 22/139 | 2.07% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 11.25% | -10.29% | 60.71% | 12/139 | 0.51% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 7% | -11.39% | 43.74% | 13/139 | 1.91% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 4.87% | -10.64% | -57.43% | 6/139 | 1.04% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 11.44% | -33.49% | -8.77% | 18/139 | 3.02% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 12.54% | -38.8% | 58.73% | 12/139 | 4.75% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 7.9% | -33.89% | 44.95% | 10/139 | 2.98% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 5.45% | -21.92% | -68.31% | 8/139 | 1.65% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 17.2% | 25.27% | -16.06% | 7/139 | 4.92% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 20.49% | 56.89% | 71.46% | 4/139 | 5.8% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 11.95% | 60.62% | 71.2% | 5/139 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 6.98% | 27.84% | -49.16% | 6/139 | 2.28% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 13.73% | -19.71% | 5.13% | 45/139 | 12.93% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 13.06% | -25.41% | 75.54% | 39/139 | 12.7% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 7.44% | -35.36% | 36.26% | 47/139 | 9.24% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 5.46% | -8.85% | -68.07% | 27/139 | 6.21% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 17.1% | -29.37% | -2.34% | 49/139 | 17.28% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 17.51% | -22.93% | 52.13% | 32/139 | 15.82% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 11.51% | -26.12% | 92.15% | 42/139 | 11.46% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 5.99% | -1.96% | -75.26% | 28/139 | 6.18% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 24.21% | 96.99% | 6.56% | 36/139 | 25.47% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 22.72% | 83.52% | 45.83% | 22/139 | 19.63% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 15.58% | 74.08% | 154.99% | 29/139 | 15.03% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 6.11% | 39.18% | -50.28% | 14/139 | 3.37% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 12.29% | 1.57% | -0.73% | 66/139 | 14.24% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 12.38% | 8.5% | 38.32% | 21/139 | 10.37% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 8.95% | 9.68% | 103.87% | 20/139 | 6.65% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 4.39% | 9.75% | -63.72% | 10/139 | 2.68% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 12.1% | 22.84% | 6.05% | 60/139 | 12.87% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 11.41% | 9.29% | 39.83% | 18/139 | 7.11% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 8.16% | 7.23% | 104% | 15/139 | 3.2% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 4% | 7.82% | -59.39% | 15/139 | 2.61% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 9.85% | -29.69% | -5.65% | 65/139 | 13.76% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 10.44% | -42.98% | 37.19% | 22/139 | 9.4% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 7.61% | -43.59% | 105.12% | 23/139 | 5.88% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 3.71% | -43.01% | -73.52% | 10/139 | 2.65% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 14.01% | -22.81% | -23.48% | 38/139 | 16.11% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 18.31% | 5.65% | 35.73% | 5/139 | 8.66% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 13.49% | 11.58% | 107.22% | 8/139 | 6.24% | *ST明德 | 23.29% | 行业排名> |
| 2016-03-31 | 6.51% | 7.96% | -64.13% | 2/139 | 2.17% | 健帆生物 | 7.75% | 行业排名> |